Immuneering Corporation
IMRX
$5.05
-$0.40-7.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.58M | -14.96M | -14.43M | -15.05M | -18.05M |
| Total Depreciation and Amortization | 83.20K | 86.20K | 91.80K | 92.60K | 93.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.57M | 1.54M | 1.61M | 1.78M | 1.76M |
| Change in Net Operating Assets | 82.60K | 1.36M | 3.29M | -902.50K | 1.69M |
| Cash from Operations | -9.84M | -11.98M | -9.45M | -14.08M | -14.51M |
| Capital Expenditure | -123.90K | -7.30K | -2.10K | -8.90K | -9.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -88.60M | -- | -- | -- | 5.50M |
| Cash from Investing | -88.72M | -7.30K | -2.10K | -8.90K | 5.49M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 429.80K | 216.27M | 2.10K | 13.81M | 100.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -787.40K | -3.07M | -64.00K | -- | -141.00K |
| Cash from Financing | -357.50K | 213.19M | -62.00K | 13.81M | -41.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -98.92M | 201.21M | -9.51M | -279.00K | -9.06M |